Skip to main content
Fig. 2 | Clinical Proteomics

Fig. 2

From: Prediction of neoadjuvant chemotherapeutic efficacy in patients with locally advanced gastric cancer by serum IgG glycomics profiling

Fig. 2

The abundance of significantly different summarized-traits in patients with response and without response to NACT. RG represents NACT response group, while NRG represents NACT non-response group. The N-glycans were grouped according to their structural features, a the proportion of sialylation in total IgG glycans (S1 total); b the proportion of agalactosylated N-glycosylation in total IgG glycans (G0 total); c The proportion of digalactosylated N-glycosylation in total IgG glycans (G2 total); d the ratio of agalactosylated N-glycosylation to galactosylated structures of fucosylated glycans (Gal-ratio); e the proportion of agalactosylated structures in total fucosylated glycans (FG0); f the proportion of digalactosylated structures in total fucosylated glycans (FG2)

Back to article page

Clinical Proteomics

ISSN: 1559-0275